Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Workday, Inc. (NASDAQ: WDAY) Chief Accounting Officer Mark S. Garfield executed a sale of 918 shares on July 10, 2026, generating proceeds of $130,530 at $142.19 per share. The transaction was facilitated through a Rule 10b5-1 trading plan established on October 14, 2025. Following the disposition, Garfield retains direct ownership of 73,718 shares…
RA Capital Management funds have executed recent purchases of Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) common stock, adding to their existing institutional positions. This buying activity occurs against a backdrop of significant clinical developments for the biotechnology company, including a Regenerative Medicine Advanced Therapy designation fr…
Jayshree Ullal, Chief Executive Officer and Chairperson of Arista Networks, Inc. (NASDAQ:ANET), executed a significant divestiture of 234,578 shares on July 10, 2026, realizing approximately $43.9 million. The transactions were conducted under a Rule 10b5-1 trading plan established in November 2025, a mechanism designed to facilitate predetermined …
RCB Equities 1, LLC executed a significant portfolio adjustment in Nauticus Robotics, Inc. (NASDAQ: KITT) on June 1, 2026, combining a direct equity sale with a major debt-to-equity conversion. This dual action alters the firm's ownership stake as the company continues to manage substantial financial pressures and seasonal operational weaknesses in…
Kate DeHoff, Chief Legal Officer and Corporate Secretary at Joby Aviation, Inc. (NASDAQ: JOBY), executed a series of stock transactions in mid-July 2026, resulting in the sale of 22,621 shares valued at approximately $173,184. These transactions were driven by distinct mechanisms: a portion covered tax liabilities from restricted stock unit (RSU) v…
Disc Medicine, Inc. CEO John D. Quisel executed a series of transactions on July 13, 2026, resulting in the sale of 33,000 shares valued at approximately $2.47 million. The activity was conducted under a Rule 10b5-1 trading plan established earlier in the year, involving the exercise of stock options and subsequent sales across multiple price point…
Joby Aviation, Inc. (NASDAQ: JOBY) Chief Product Officer Eric Allison executed a sale of company equity on July 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The transaction involved the liquidation of 27,932 shares, generating a total proceeds value of $210,327. The sale was necessitated by tax obligations ass…
EverCommerce Inc. (NASDAQ: EVCM) Chief Executive Officer Eric Richard Remer sold 19,200 shares of company stock on July 14, 2026, generating $206,693 in proceeds. The sale was conducted under a Rule 10b5-1 trading plan established on June 12, 2026. Following the transaction, Mr. Remer directly holds 5,660,251 shares, with additional indirect holdin…
Jay A. Bys, serving as Executive Vice President and Chief Commercial Officer at California Resources Corp (NASDAQ:CRC), executed a sale of company equity on July 13, 2026. The transaction involved the disposal of 11,907 shares at a price of $54.0 per share, resulting in a total value of $642,978. This sale was conducted automatically under a Rule 1…
PRO DEX INC (NASDAQ:PDEX) director Angelita Rebamontan Domingo executed a share sale on March 16, 2026, disposing of 998 shares at $47.24 each for a total proceeds of $47,145. The director now holds a direct position of 18,779 shares. While the sale reduces her immediate exposure, the company's stock has since rallied 23% to $58.26, driven by stron…
Paul Caine, a director at Magnite Inc. (NASDAQ: MGNI), executed a transaction on July 10, 2026, selling 5,000 shares of the company's common stock. The total value of the sale reached $103,200, with shares transacted at a weighted average price of $20.64. The transaction was facilitated through a Rule 10b5-1 trading plan established by Caine on Aug…
Maurice J. Duca, a significant ten percent stakeholder in AppFolio Inc. (NASDAQ: APPF), has executed a series of stock sales totaling $1,981,605 in early July 2026. The transactions, conducted under a pre-arranged 10b5-1 trading plan, involved both direct share disposals and sales from trusts where Duca holds fiduciary roles. This activity occurs a…
Planet Labs PBC director John Raymond completed a stock sale totaling $169,871 on July 13, 2026. The transaction involved the disposition of 6,494 Class A Common shares, executed via a Rule 10b5-1 trading plan established earlier in the year. This insider activity occurs against a backdrop of significant operational milestones for Planet Labs and c…
William J.G. Griffith, a director and significant shareholder of Netskope Inc (NASDAQ:NTSK), has executed a substantial acquisition of the company's Class A Common Stock. The purchases, totaling approximately $3.77 million, were conducted through ICONIQ Strategic Partners funds over two dates in July 2026. This activity occurs as Netskope reports s…
ICONIQ Strategic Partners VIII Holdings, L.P., associated with 10% owner Divesh Makan, recently purchased approximately $3.77 million of Netskope Inc (NASDAQ:NTSK) Class A Common Stock across two dates in July 2026. The acquisition brings the fund's direct holdings to 916,690 shares. While the stock has gained approximately 16% from the weighted av…
Karen Golz, a director at Analog Devices Inc. (NASDAQ: ADI), executed a sale of 1,000 shares on July 13, 2026, totaling $389,830. The transaction was facilitated through a 10b5-1 trading plan established in March 2026 and occurred as the company’s stock has shown significant gains over the past year. Following the sale, Golz retains a direct holdin…
Mink Brook Asset Management LLC has increased its position in DLH Holdings Corp. (NASDAQ:DLHC), purchasing 4,407 shares on July 13, 2026. The acquisition brings the total beneficial ownership of Mink Brook Partners LP to 2,158,480 shares. This transaction occurs as DLH Holdings undergoes significant leadership changes, including the retirement of C…
Regional Management Corp. (NYSE: RM) reported that Steven B. Barnette, Vice President and Chief Accounting Officer, sold 3,274 shares of the company's common stock on July 10, 2026. The transaction, valued at $141,764, was executed under a Rule 10b5-1 trading plan established on December 1, 2025. This sale occurs against a backdrop of recent corpor…
Anthony Bacos, Stitch Fix’s Chief Product and Technology Officer, sold 70,000 shares of the company’s Class A Common Stock on July 13, 2026, realizing $253,144 from the transaction. The sales were executed under a Rule 10b5-1 trading plan established in March 2026, with shares sold at prices between $3.57 and $3.66. The transaction follows a recent…
Josh Silverman, Executive Chair of Etsy Inc. (NASDAQ:ETSY), executed a series of structured transactions involving the company's common stock on July 10, 2026. Under a pre-established Rule 10b5-1 trading plan adopted in November 2025, Silverman acquired 39,161 shares via employee stock option exercises at $10.62 per share, totaling $415,889, and im…
Konstantin Lomashuk, a significant 10% stakeholder in Forum Markets Inc (NASDAQ: FRMM), executed a sale of his company's common stock on July 9, 2026. The transaction, totaling approximately $20,846, involved the disposition of 3,387 shares at a per-share price of $6.1548. These securities were held indirectly through Cyber Citadel, a Cayman Island…
Shachar Erez, serving as a director at RISKIFIED LTD. (NASDAQ:RSKD), executed a series of transactions resulting in the sale of 106,431 Class A Ordinary Shares, generating proceeds of approximately $555,125. These sales were facilitated indirectly by Qumra Capital I L.P. and Qumra Capital I Continuation Fund L.P. under a Rule 10b5-1 trading plan es…
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported executive stock activity and clinical trial updates. CEO Claire Mazumdar executed sales and acquisitions under a pre-arranged trading plan. The company also presented extended follow-up data from a Phase 1/1b study on ficerafusp alfa combined with pembrolizumab. Analysts maintained ratings and price …
John Colgrove, Chief Visionary Officer and director at Everpure, Inc. (NASDAQ:P), executed a series of share sales totaling approximately $7,982,329 on July 10, 2026. The transactions were facilitated through pre-arranged Rule 10b5-1 trading plans, with proceeds distributed via two irrevocable trusts benefiting immediate family members. Following t…
Michael Henry Fiore, Executive Vice President and Chief Commercial Officer at HealthEquity, Inc. (NASDAQ: HQY), recently completed a stock transaction involving the sale of 2,354 shares on July 10, 2026. The transaction, valued at $223,630, was executed at a price of $95.00 per share. Following this disposition, Fiore retains direct ownership of 52…
